Source: Brazilian Journal of Medical and Biological Research. Unidades: FMRP, FM
Subjects: CARCINOMA, NEOPLASIAS PULMONARES, FARMACOTERAPIA, MUTAÇÃO GENÉTICA, PROTEÍNAS QUINASES
ABNT
MACHADO-RUGOLO, Juliana et al. Clinical outcome of Brazilian patients with non-small cell lung cancer in early stage harboring rare mutations in epidermal growth factor receptor. Brazilian Journal of Medical and Biological Research, v. 55, p. 1-10, 2022Tradução . . Disponível em: https://doi.org/10.1590/1414-431X2022e12409. Acesso em: 26 nov. 2025.APA
Machado-Rugolo, J., Baldavira, C. M., Prieto, T. G., Olivieri, E. H. R., Fabro, A. T., Rainho, C. A., et al. (2022). Clinical outcome of Brazilian patients with non-small cell lung cancer in early stage harboring rare mutations in epidermal growth factor receptor. Brazilian Journal of Medical and Biological Research, 55, 1-10. doi:10.1590/1414-431X2022e12409NLM
Machado-Rugolo J, Baldavira CM, Prieto TG, Olivieri EHR, Fabro AT, Rainho CA, Castelli EC, Ribolla PEM, Ab'Saber AM, Takagaki TY, Nagai MA, Capelozzi VL. Clinical outcome of Brazilian patients with non-small cell lung cancer in early stage harboring rare mutations in epidermal growth factor receptor [Internet]. Brazilian Journal of Medical and Biological Research. 2022 ; 55 1-10.[citado 2025 nov. 26 ] Available from: https://doi.org/10.1590/1414-431X2022e12409Vancouver
Machado-Rugolo J, Baldavira CM, Prieto TG, Olivieri EHR, Fabro AT, Rainho CA, Castelli EC, Ribolla PEM, Ab'Saber AM, Takagaki TY, Nagai MA, Capelozzi VL. Clinical outcome of Brazilian patients with non-small cell lung cancer in early stage harboring rare mutations in epidermal growth factor receptor [Internet]. Brazilian Journal of Medical and Biological Research. 2022 ; 55 1-10.[citado 2025 nov. 26 ] Available from: https://doi.org/10.1590/1414-431X2022e12409
